Therefore resveratrol, or more potent Sirt-1 activators [39], may provide a pharmacological means to increase PGC-1α signaling in both mdx mice and eventually in DMD patients. The gene discussed is PPARGC1A; the disease is Duchenne muscular dystrophy.